SANDOSTATIN LAR
Total Payments
$300,447
Transactions
2,488
Doctors
1,335
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $263.06 | 19 | 17 |
| 2019 | $57,456 | 302 | 231 |
| 2018 | $170,045 | 1,099 | 687 |
| 2017 | $72,683 | 1,068 | 733 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $134,545 | 44 | 44.8% |
| Space rental or facility fees (teaching hospital only) | $63,580 | 66 | 21.2% |
| Food and Beverage | $40,593 | 2,321 | 13.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,020 | 8 | 9.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $20,658 | 6 | 6.9% |
| Travel and Lodging | $9,268 | 37 | 3.1% |
| Unspecified | $3,783 | 6 | 1.3% |
Payments by Type
General
$296,664
2,482 transactions
Research
$3,783
6 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| OUTCOMES RESEARCH | NOVARTIS PHARMACEUTICALS CORPORATION | $3,783 | 2 |
Top Doctors Receiving Payments for SANDOSTATIN LAR
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Santa Barbara, CA | $63,691 | 74 |
| , M.D | Surgical Oncology | Denver, CO | $18,897 | 14 |
| , M.D | Hematology | Baltimore, MD | $15,558 | 12 |
| , M.D | Neuropathology | Boston, MA | $13,770 | 10 |
| , M.D | Hematology & Oncology | Durham, NC | $13,564 | 10 |
| , MD | Surgery | Portland, OR | $11,906 | 7 |
| , M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $8,864 | 4 |
| , M.D | Hematology & Oncology | Lexington, KY | $8,374 | 6 |
| , MD | Internal Medicine | Boston, MA | $8,035 | 6 |
| , M.D | Medical Oncology | Houston, TX | $7,973 | 6 |
| , M.D | Medical Oncology | Stanford, CA | $7,599 | 3 |
| , MD | Nuclear Radiology | New York, NY | $7,196 | 4 |
| , MD | Internal Medicine | Boston, MA | $7,077 | 3 |
| , MD | Medical Oncology | Tampa, FL | $5,664 | 6 |
| , D.O | Internal Medicine | Kenner, LA | $5,339 | 3 |
| , MD | Hematology & Oncology | Orlando, FL | $5,223 | 7 |
| , MD | Medical Oncology | Buffalo, NY | $5,000 | 5 |
| , MD, MS | Hematology & Oncology | New York, NY | $4,474 | 2 |
| , MD | Hematology & Oncology | Rochester, NY | $4,126 | 4 |
| , M.D | Medical Oncology | Cleveland, OH | $3,849 | 2 |
| , MD | Gastroenterology | New York, NY | $3,738 | 6 |
| , MD, MPH | Internal Medicine | West Hollywood, CA | $3,469 | 6 |
| , MD | Hematology & Oncology | Great Neck, NY | $3,400 | 2 |
| , M.D | Medical Oncology | Philadelphia, PA | $3,275 | 1 |
| , M.D., PH.D | Nuclear Medicine | Portland, OR | $3,051 | 4 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $300,447
- Total Doctors 1,335
- Transactions 2,488
About SANDOSTATIN LAR
SANDOSTATIN LAR is a drug associated with $300,447 in payments to 1,335 healthcare providers, recorded across 2,488 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharmaceuticals Corporation.
Payment data is available from 2017 to 2020. In 2020, $263.06 was paid across 19 transactions to 17 doctors.
The most common payment nature for SANDOSTATIN LAR is "Consulting Fee" ($134,545, 44.8% of total).
SANDOSTATIN LAR is associated with 1 research study, including "OUTCOMES RESEARCH" ($3,783).